EE200200295A - Adamantaani derivaadid - Google Patents
Adamantaani derivaadidInfo
- Publication number
- EE200200295A EE200200295A EEP200200295A EEP200200295A EE200200295A EE 200200295 A EE200200295 A EE 200200295A EE P200200295 A EEP200200295 A EE P200200295A EE P200200295 A EEP200200295 A EE P200200295A EE 200200295 A EE200200295 A EE 200200295A
- Authority
- EE
- Estonia
- Prior art keywords
- adamantane derivatives
- adamantane
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904505A SE9904505D0 (sv) | 1999-12-09 | 1999-12-09 | Novel compounds |
PCT/SE2000/002418 WO2001042194A1 (en) | 1999-12-09 | 2000-12-01 | Adamantane derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200200295A true EE200200295A (et) | 2003-08-15 |
Family
ID=20418060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200295A EE200200295A (et) | 1999-12-09 | 2000-12-01 | Adamantaani derivaadid |
Country Status (27)
Country | Link |
---|---|
US (1) | US6720452B2 (xx) |
EP (1) | EP1240132B1 (xx) |
JP (1) | JP2003516382A (xx) |
KR (1) | KR20020060991A (xx) |
CN (1) | CN1407968A (xx) |
AR (1) | AR032139A1 (xx) |
AT (1) | ATE263748T1 (xx) |
AU (1) | AU2036301A (xx) |
BR (1) | BR0016227A (xx) |
CA (1) | CA2394236A1 (xx) |
CO (1) | CO5261526A1 (xx) |
CZ (1) | CZ20021982A3 (xx) |
DE (1) | DE60009747T2 (xx) |
EE (1) | EE200200295A (xx) |
HK (1) | HK1046527A1 (xx) |
HU (1) | HUP0300618A3 (xx) |
IL (1) | IL149762A0 (xx) |
IS (1) | IS6405A (xx) |
MX (1) | MXPA02005668A (xx) |
NO (1) | NO20022727L (xx) |
NZ (1) | NZ518985A (xx) |
PL (1) | PL357103A1 (xx) |
RU (1) | RU2002118213A (xx) |
SE (1) | SE9904505D0 (xx) |
SK (1) | SK7622002A3 (xx) |
WO (1) | WO2001042194A1 (xx) |
ZA (1) | ZA200203834B (xx) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI258462B (en) | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
SE9904738D0 (sv) * | 1999-12-22 | 1999-12-22 | Astra Pharma Prod | Novel compounds |
PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
SE0200920D0 (sv) * | 2002-03-25 | 2002-03-25 | Astrazeneca Ab | Novel compounds |
PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
US7071223B1 (en) * | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
SE0300445D0 (sv) * | 2003-02-18 | 2003-02-18 | Astrazeneca Ab | New combination |
SE0300480D0 (sv) * | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
JP4731468B2 (ja) * | 2003-05-12 | 2011-07-27 | ファイザー・プロダクツ・インク | P2x7受容体のベンズアミド阻害剤 |
US20070010497A1 (en) * | 2003-05-29 | 2007-01-11 | Nigel Boughton-Smith | Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
EP1633401A1 (en) * | 2003-05-29 | 2006-03-15 | AstraZeneca AB | A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
WO2004105796A1 (en) * | 2003-05-29 | 2004-12-09 | Astrazeneca Ab | A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate |
SE0302192D0 (sv) * | 2003-08-08 | 2003-08-08 | Astrazeneca Ab | Novel compounds |
SE0302488D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | New combination |
AU2005258911A1 (en) * | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3H`1,2,4!triazin-2-YL!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
WO2006003513A1 (en) * | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
EP1763353A1 (en) * | 2004-06-29 | 2007-03-21 | Warner-Lambert Company LLC | COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR |
SA05260265A (ar) * | 2004-08-30 | 2005-12-03 | استرازينيكا ايه بي | مركبات جديدة |
US20060063834A1 (en) * | 2004-09-09 | 2006-03-23 | Frangioni John V | Substituted adamantanes, and methods of making the same |
SE0402925D0 (sv) * | 2004-11-30 | 2004-11-30 | Astrazeneca Ab | Novel Compounds |
KR100643514B1 (ko) * | 2005-05-17 | 2006-11-23 | (주)아모레퍼시픽 | 히드록시벤조산 아미드 화합물과 그 제조방법 및 이를함유하는 미백화장료 조성물 |
WO2007008157A1 (en) * | 2005-07-11 | 2007-01-18 | Astrazeneca Ab | New combination 2 |
EP1906960A4 (en) * | 2005-07-11 | 2010-03-10 | Astrazeneca Ab | NEW COMBINATION 1 |
EP2096923B1 (en) | 2006-11-27 | 2014-01-22 | H. Lundbeck A/S | Heteroaryl amide derivatives |
EP2203429A1 (en) | 2007-10-31 | 2010-07-07 | Nissan Chemical Industries, Ltd. | Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
NZ587799A (en) | 2008-03-25 | 2012-06-29 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
KR20100053150A (ko) * | 2008-11-12 | 2010-05-20 | 한국생명공학연구원 | 아릴옥시아세틸계 유도체를 유효성분으로 포함하는 dna 메틸트렌스퍼레이즈 억제용 약학적 조성물 |
CN102395562A (zh) | 2009-04-14 | 2012-03-28 | 阿费克蒂斯制药股份公司 | 新的p2x7r拮抗剂及其用途 |
EP2322149A1 (en) | 2009-11-03 | 2011-05-18 | Universidad del Pais Vasco | Methods and compositions for the treatment of ischemia |
EP2386541A1 (en) | 2010-05-14 | 2011-11-16 | Affectis Pharmaceuticals AG | Novel methods for the preparation of P2X7R antagonists |
WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
BR112014001454A2 (pt) | 2011-07-22 | 2017-06-27 | Actelion Pharmaceuticals Ltd | derivados de amidas heterocíclicas como antagonistas do receptor de p2x7 |
KR101957843B1 (ko) * | 2011-10-06 | 2019-03-14 | (주)아모레퍼시픽 | 신규 아다만탄 유도체 화합물 |
JP6111268B2 (ja) | 2012-01-20 | 2017-04-05 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | P2x7受容体アンタゴニストとしての複素環アミド誘導体 |
EP2931717B1 (en) | 2012-12-12 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Indole carboxamide derivatives as p2x7 receptor antagonists |
US9556117B2 (en) | 2012-12-18 | 2017-01-31 | Actelion Pharmaceuticals Ltd. | Indole carboxamide derivatives as P2X7 receptor antagonists |
EP2956457B1 (en) | 2013-01-22 | 2016-11-23 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
EP2956135B1 (en) | 2013-01-22 | 2016-11-16 | Actelion Pharmaceuticals Ltd. | Heterocyclic amide derivatives as p2x7 receptor antagonists |
WO2021153720A1 (ja) | 2020-01-31 | 2021-08-05 | クミアイ化学工業株式会社 | 3-アルコキシ安息香酸アミド誘導体及び有害生物防除剤 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3464998A (en) | 1968-03-04 | 1969-09-02 | Searle & Co | Adamantyl esters and amides of pyridinecarboxylic acids |
US3732305A (en) | 1970-03-03 | 1973-05-08 | Us Army | S-substituted thiosulfuric acid derivatives and preparation thereof |
US3789072A (en) | 1970-04-22 | 1974-01-29 | Squibb & Sons Inc | Carboxamides |
CA2015473C (en) | 1989-04-28 | 1998-04-14 | Iwao Kinoshita | Triphenylmethane derivatives |
CA2091194A1 (en) | 1992-04-08 | 1993-10-09 | Richard D. Connell | 2-oxo-ethyl derivatives as immunosuppressants |
ATE197146T1 (de) | 1993-08-10 | 2000-11-15 | Black James Foundation | Gastrin-und cck-rezeptorligande |
US5912260A (en) | 1994-05-27 | 1999-06-15 | James Black Foundation Limited | Gastrin and CCK antagonists |
DE19608653A1 (de) | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
SE9704544D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
SE9704546D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
SE9704545D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
BR0009651A (pt) * | 1999-04-09 | 2002-01-08 | Astrazeneca Ab | Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas |
SE9901875D0 (sv) | 1999-05-25 | 1999-05-25 | Astra Pharma Prod | Novel compounds |
TWI258462B (en) | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
SE9904652D0 (sv) | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
SE9904738D0 (sv) | 1999-12-22 | 1999-12-22 | Astra Pharma Prod | Novel compounds |
-
1999
- 1999-12-09 SE SE9904505A patent/SE9904505D0/xx unknown
-
2000
- 2000-12-01 CN CN00816771A patent/CN1407968A/zh active Pending
- 2000-12-01 AU AU20363/01A patent/AU2036301A/en not_active Abandoned
- 2000-12-01 PL PL00357103A patent/PL357103A1/xx not_active Application Discontinuation
- 2000-12-01 US US10/149,190 patent/US6720452B2/en not_active Expired - Fee Related
- 2000-12-01 BR BR0016227-2A patent/BR0016227A/pt not_active Application Discontinuation
- 2000-12-01 EP EP00983632A patent/EP1240132B1/en not_active Expired - Lifetime
- 2000-12-01 MX MXPA02005668A patent/MXPA02005668A/es unknown
- 2000-12-01 HU HU0300618A patent/HUP0300618A3/hu unknown
- 2000-12-01 CZ CZ20021982A patent/CZ20021982A3/cs unknown
- 2000-12-01 RU RU2002118213/04A patent/RU2002118213A/ru unknown
- 2000-12-01 JP JP2001543496A patent/JP2003516382A/ja not_active Withdrawn
- 2000-12-01 AT AT00983632T patent/ATE263748T1/de not_active IP Right Cessation
- 2000-12-01 CA CA002394236A patent/CA2394236A1/en not_active Abandoned
- 2000-12-01 NZ NZ518985A patent/NZ518985A/en unknown
- 2000-12-01 DE DE60009747T patent/DE60009747T2/de not_active Expired - Lifetime
- 2000-12-01 EE EEP200200295A patent/EE200200295A/xx unknown
- 2000-12-01 IL IL14976200A patent/IL149762A0/xx unknown
- 2000-12-01 SK SK762-2002A patent/SK7622002A3/sk unknown
- 2000-12-01 KR KR1020027007354A patent/KR20020060991A/ko not_active Application Discontinuation
- 2000-12-01 WO PCT/SE2000/002418 patent/WO2001042194A1/en active IP Right Grant
- 2000-12-04 AR ARP000106417A patent/AR032139A1/es unknown
- 2000-12-06 CO CO00093169A patent/CO5261526A1/es not_active Application Discontinuation
-
2002
- 2002-05-14 ZA ZA200203834A patent/ZA200203834B/xx unknown
- 2002-05-31 IS IS6405A patent/IS6405A/is unknown
- 2002-06-07 NO NO20022727A patent/NO20022727L/no not_active Application Discontinuation
- 2002-11-05 HK HK02108042.9A patent/HK1046527A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
SE9904505D0 (sv) | 1999-12-09 |
DE60009747D1 (de) | 2004-05-13 |
HUP0300618A2 (hu) | 2003-07-28 |
JP2003516382A (ja) | 2003-05-13 |
DE60009747T2 (de) | 2005-04-28 |
IL149762A0 (en) | 2002-11-10 |
SK7622002A3 (en) | 2003-01-09 |
US6720452B2 (en) | 2004-04-13 |
HUP0300618A3 (en) | 2003-12-29 |
ZA200203834B (en) | 2003-08-14 |
NO20022727D0 (no) | 2002-06-07 |
CO5261526A1 (es) | 2003-03-31 |
BR0016227A (pt) | 2002-10-01 |
NZ518985A (en) | 2004-02-27 |
NO20022727L (no) | 2002-07-29 |
WO2001042194A1 (en) | 2001-06-14 |
EP1240132B1 (en) | 2004-04-07 |
EP1240132A1 (en) | 2002-09-18 |
IS6405A (is) | 2002-05-31 |
US20020193414A1 (en) | 2002-12-19 |
CA2394236A1 (en) | 2001-06-14 |
AU2036301A (en) | 2001-06-18 |
RU2002118213A (ru) | 2004-01-10 |
MXPA02005668A (es) | 2002-09-02 |
KR20020060991A (ko) | 2002-07-19 |
CZ20021982A3 (cs) | 2003-01-15 |
ATE263748T1 (de) | 2004-04-15 |
PL357103A1 (en) | 2004-07-12 |
CN1407968A (zh) | 2003-04-02 |
AR032139A1 (es) | 2003-10-29 |
HK1046527A1 (zh) | 2003-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100525A (et) | Adamantaani derivaadid | |
EE200200330A (et) | Adamantaani derivaadid | |
EE200200295A (et) | Adamantaani derivaadid | |
NO20000885L (no) | 4-Fenyl-pyridin-derivater | |
NO20021077D0 (no) | Amino-triazolopyridin-derivater | |
ATE293104T1 (de) | Thiazolylamid-derivate | |
IS6128A (is) | 13-Metýl-erýþrómýsín afleiður | |
DK1187814T3 (da) | 5-phenyl-pyrimidinderivater | |
ATE338021T1 (de) | Substituierte 2-dialkylaminoalkylbiphenyl- derivate | |
NO20021803D0 (no) | Isoksazolkarboksamid-derivater | |
PT1237857E (pt) | Novos derivados fenalquiloxi-fenilo | |
ATE257148T1 (de) | Propargyletherderivate | |
ATE374747T1 (de) | Monofluoralkylderivate | |
DK1154988T3 (da) | Mevinolinderivater | |
DE60006703D1 (de) | 4-hydroxybiphenylhydrazid-derivate | |
DK1187815T3 (da) | 4-phenyl-pyrimidinderivater | |
ATE293592T1 (de) | Resorcinderivate | |
NO20020212L (no) | 3-amino-2-benzyl-1-fenyl-propanderivater | |
NO20022867D0 (no) | Syklopentenon-derivater | |
TR200002831A3 (tr) | Kinolin-4-Il türevleri I | |
DE60025348D1 (de) | Ethansulfonyl-piperidin-derivate | |
DK1178984T3 (da) | 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater | |
DE59909774D1 (de) | 1-cycloalkylpyrazolyl-benzoyl-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HD1A | Correction of address |